The Effect of Bone Marrow-Derived Mesenchymal Stem Cell Transplantation on Allodynia and Hyperalgesia in Neuropathic Animals: A Systematic Review with Meta-Analysis

Biology of Blood and Marrow Transplantation

Volumn 21, Issue 9, 2015, Pages 1537-1544

  Hosseini, Mostafa ^a   Yousefifard, Mahmoud ^b   Aziznejad, Heidar ^c   Nasirinezhad, Farinaz ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Allodynia; Hyperalgesia; Mesenchymal stromal cells; Meta analysis; Neuropathic pain

Indexed keywords

ALLODYNIA; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CENTRAL NEUROPATHY; CLINICAL EFFECTIVENESS; EFFECT SIZE; FOLLOW UP; HYPERALGESIA; INJURY; MESENCHYMAL STEM CELL TRANSPLANTATION; META ANALYSIS; NEUROPATHIC PAIN; NONHUMAN; PAIN; PERIPHERAL NEUROPATHY; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ANIMAL; BONE MARROW CELL; MESENCHYMAL STROMA CELL; METABOLISM; NEURALGIA; PATHOLOGY;

ANIMALS; BONE MARROW CELLS; HYPERALGESIA; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NEURALGIA;

EID: 84938971652     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2015.05.008     Document Type: Review

References (68)

1. Jensen T.S., Baron R., Haanpää M., et al. A new definition of neuropathic pain. Pain 2011, 152:2204-2205.
2. Nurcan Ã.Ã., Sommer C. Neuropathic pain assessment: an overview of existing guidelines and discussion points for the future. Eur Neurol Rev 2011, 6:128-131.
3. Van Hecke O., Austin S.K., Khan R.A., et al. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain 2014, 155:654-662.
4. Bennett M.I., Smith B.H., Torrance N., Lee A.J. Can pain can be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by clinicians. Pain 2006, 122:289-294.
5. Dieleman J.P., Kerklaan J., Huygen F.J., et al. Incidence rates and treatment of neuropathic pain conditions in the general population. Pain 2008, 137:681-688.
6. Klass M., Gavrikov V., Drury D., et al. Intravenous mononuclear marrow cells reverse neuropathic pain from experimental mononeuropathy. Anesth Analg 2007, 104:944-948.
7. Klein S., Svendsen C.N. Stem cells in the injured spinal cord: reducing the pain and increasing the gain. Nat Neurosci 2005, 8:259-260.
8. Jergova S., Hentall I.D., Gajavelli S., et al. Intraspinal transplantation of GABAergic neural progenitors attenuates neuropathic pain in rats: a pharmacologic and neurophysiological evaluation. Exp Neurol 2012, 234:39-49.
9. Borsani E., Franchi S., Rossi A., et al. Stem cell transplantation in neuropathic pain. Ital J Anot Emberyol 2011, 116:31.
10. Lin C.R., Wu P.C., Shih H.C., et al. Intrathecal spinal progenitor cell transplantation for the treatment of neuropathic pain. Cell Transplant 2002, 11:17-24.
11. Eaton M., Plunkett J., Martinez M., et al. Transplants of neuronal cells bioengineered to synthesize GABA alleviate chronic neuropathic pain. Cell Transplant 1999, 8:87.
12. Liang Y., Jiang W., Zhang Z., et al. Behavioral and morphological evidence for the involvement of glial cells in the antinociceptive effect of najanalgesin in a rat neuropathic pain model. Biol Pharm Bull 2012, 35:850-854.
13. Pirhajati Mahabadi V., Tiraih T., Khalatbary A. Central neuropathic pain after graft of bone marrow stromal cells in the spinal cord contusion of rat. J Iran Anatomic Sci 2007, 5:93-105.
14. Klopp A.H., Gupta A., Spaeth E., et al. Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?. Stem Cells 2011, 29:11-19.
15. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
16. Anjos-Afonso F., Siapati E.K., Bonnet D. In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J Cell Sci 2004, 117:5655-5664.
17. Wakitani S., Imoto K., Yamamoto T., et al. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 2002, 10:199-206.
18. Nauta A.J., Fibbe W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007, 110:3499-3506.
19. Puissant B., Barreau C., Bourin P., et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005, 129:118-129.
20. Bae J.S., Han H.S., Youn D.H., et al. Bone marrow-derived mesenchymal stem cells promote neuronal networks with functional synaptic transmission after transplantation into mice with neurodegeneration. Stem Cells 2007, 25:1307-1316.
21. Cho K.J., Trzaska K.A., Greco S.J., et al. Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1α. Stem Cells 2005, 23:383-391.
22. Amemori T., Jendelová P., Ruzicková K., et al. Co-transplantation of olfactory ensheathing glia and mesenchymal stromal cells does not have synergistic effects after spinal cord injury in the rat. Cytotherapy 2010, 12:212-225.
23. Guo W., Wang H., Zou S., et al. Bone marrow stromal cells produce long-term pain relief in rat models of persistent pain. Stem Cells 2011, 29:1294-1303.
24. Kumagai G., Tsoulfas P., Toh S., et al. Genetically modified mesenchymal stem cells (MSCs) promote axonal regeneration and prevent hypersensitivity after spinal cord injury. Exp Neurol 2013, 248:369-380.
25. Kishk N.A., Gabr H., Hamdy S., et al. Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury. Neurorehabil Neural Repair 2010, 24:702-708.
26. Ichim T.E., Solano F., Lara F., et al. Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report. Int Arch Med 2010, 3:30.
27. Syková E., Homola A., Mazanec R., et al. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant 2006, 15:675-687.
28. Geffner L., Santacruz P., Izurieta M., et al. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant 2008, 17:1277-1293.
29. Kumar A.A., Kumar S.R., Narayanan R., et al. Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: a phase I/II clinical safety and primary efficacy data. Exp Clin Transplant 2009, 7:241-248.
30. Pal R., Venkataramana N.K., Bansal A., et al. Ex vivo expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study. Cytotherapy 2009, 11:897-911.
31. Moviglia G., Varela G., Gaeta C., et al. Autoreactive T cells induce in vitro BM mesenchymal stem cell transdifferentiation to neural stem cells. Cytotherapy 2006, 8:196-201.
32. Fawcett J., Curt A., Steeves J., et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 2006, 45:190-205.
33. Lee K.H., Suh-Kim H., Choi J.S., et al. Human mesenchymal stem cell transplantation promotes functional recovery following acute spinal cord injury in rats. Acta Neurobiol Exp (Wars) 2007, 67:13-22.
34. Musolino P.L., Coronel M.F., Hökfelt T., Villar M.J. Bone marrow stromal cells induce changes in pain behavior after sciatic nerve constriction. Neurosci Lett 2007, 418:97-101.
35. Neuhuber B., Timothy Himes B., Shumsky J.S., et al. Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res 2005, 1035:73-85.
36. Schäfer S., Berger J.V., Deumens R., et al. Influence of intrathecal delivery of bone marrow-derived mesenchymal stem cells on spinal inflammation and pain hypersensitivity in a rat model of peripheral nerve injury. J Neuroinflammation 2014, 11:157.
37. Siniscalco D., Giordano C., Galderisi U., et al. Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice. Front Integr Neurosci 2011, 5:79.
38. Torres-Espín A., Redondo-Castro E., Hernández J., Navarro X. Bone marrow mesenchymal stromal cells and olfactory ensheathing cells transplantation after spinal cord injury-a morphological and functional comparison in rats. Eur J Neurosci 2014, 39:1704-1717.
39. Urdzíková L., Jendelová P., Glogarová K., et al. Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. J Neurotrauma 2006, 23:1379-1391.
40. Vaquero J., Zurita M., Oya S., Santos M. Cell therapy using bone marrow stromal cells in chronic paraplegic rats: systemic or local administration?. Neurosci Lett 2006, 398:129-134.
41. Zhang E.J., Song C.H., Ko Y.K., Lee W.H. Intrathecal administration of mesenchymal stem cells reduces the reactive oxygen species and pain behavior in neuropathic rats. Korean J Pain 2014, 27:239-245.
42. Vesterinen H.M., Sena E.S., Egan K.J., et al. Meta-analysis of data from animal studies: a practical guide. J Neurosci Methods 2014, 221:92-102.
43. Sena E.S., Currie G.L., McCann S.K., et al. Systematic reviews and meta-analysis of preclinical studies: why perform them and how to appraise them critically. J Cereb Blood Flow Metab 2014, 34:737-742.
44. Chaplan S., Bach F., Pogrel J., et al. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53:55-63.
45. Montagne-Clavel J., Oliveras J.-L. The "plantar test" apparatus (Ugo Basile Biological Apparatus), a controlled infrared noxious radiant heat stimulus for precise withdrawal latency measurement in the rat, as a tool for humans?. Somatosens Mot Res 1996, 13:215-223.
46. Higgins J.P., Green S. Cochrane handbook for systematic reviews of interventions 2008, Wiley Online Library, Chichester.
47. Hozo S.P., Djulbegovic B., Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005, 5:13.
48. Sistrom C.L., Mergo P.J. A simple method for obtaining original data from published graphs and plots. Am J Roentgenol 2000, 174:1241-1244.
49. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ (Clinical Research ed) 2003, 327:557-560.
50. Egger M., Smith G.D., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
51. Ildikó R., Zimmer A. Animal models of nociception. Standards of Mouse Model Phenotyping 2009, 53:221-235. Wiley-Blackwell, Chichester.
52. Le Bars D., Gozariu M., Cadden S.W. Animal models of nociception. Pharmacol Rev 2001, 53:597-652.
53. Mogil J.S. Animal models of pain: progress and challenges. Nat Rev Neurosci 2009, 10:283-294.
54. Burnett M.G., Zager E.L. Pathophysiology of peripheral nerve injury: a brief review. Neurosurg Focus 2004, 16:1-7.
55. Scholz J., Woolf C.J. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 2007, 10:1361-1368.
56. Klusáková I., Dubový P. Experimental models of peripheral neuropathic pain based on traumatic nerve injuries-an anatomical perspective. Ann Anat 2009, 191:248-259.
57. Oyinbo C.A. Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade. Acta Neurobiol Exp (Wars) 2011, 71:281-299.
58. Montespan F., Deschaseaux F., Sensébé L., et al. Osteodifferentiated mesenchymal stem cells from bone marrow and adipose tissue express HLA-G and display immunomodulatory properties in HLA-mismatched settings: implications in bone repair therapy. J Immunol Res 2014, 2014:1-10.
59. Hou R., Liu R., Niu X., et al. Biological characteristics and gene expression pattern of bone marrow mesenchymal stem cells in patients with psoriasis. Exp Dermatol 2014, 23:521-523.
60. Menendez P., Rodriguez R., Delgado M., Rosu-Myles M. Human bone marrow mesenchymal stem cells lose immunosuppressive and anti-inflammatory properties upon oncogenic transformation. Exp Hematol 2014, 42:S49.
61. Zeng X., Zeng Y.S., Ma Y.H., et al. Bone marrow mesenchymal stem cells in a three-dimensional gelatin sponge scaffold attenuate inflammation, promote angiogenesis, and reduce cavity formation in experimental spinal cord injury. Cell Transplant 2011, 20:11-12.
62. Parr A.M., Tator C.H., Keating A. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant 2007, 40:609-619.
63. Oudega M., Ritfeld G. Bone marrow-derived mesenchymal stem cell transplant survival in the injured rodent spinal cord. J Bone Marrow Res 2014, 2:2-9.
64. Deda H., Inci M., Kürekçi A., et al. Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up. Cytotherapy 2008, 10:565-574.
65. Yoon S.H., Shim Y.S., Park Y.H., et al. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: phase I/II clinical trial. Stem Cells 2007, 25:2066-2073.
66. Pal R., Gopinath C., Rao N.M., et al. Functional recovery after transplantation of bone marrow-derived human mesenchymal stromal cells in a rat model of spinal cord injury. Cytotherapy 2010, 12:792-806.
67. Li H., Wen Y., Luo Y., et al. Transplantation of bone marrow mesenchymal stem cells into spinal cord injury: a comparison of delivery different times. Chin J Repar Reconstr Surg 2010, 24:180-184.
68. Krampera M., Cosmi L., Angeli R., et al. Role for interferon-γ in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006, 24:386-398.